Avanos Medical, Inc.
AVNSHealthcareNASDAQMedical Devices
Scan Results
Daily timeframePart of the healthcare sector, Avanos Medical, Inc. (AVNS) is listed under Medical Devices. The $1.17B market capitalization puts AVNS squarely in small-cap range for its industry. It offers digestive health products, such as Mic-Key enteral feeding tubes, Corpak patient feeding solutions, and NeoMed neonatal and pediatric feeding solutions.
Market Cap
$1.17B
Beta
1.57
P/E (TTM)
—
P/E (Fwd)
19.98
EPS (TTM)
$-1.60
EPS (Fwd)
$1.25
ROE
-9.2%
ROA
0.9%
Cash
$65.6M
Total Debt
$138.4M
Free CF
$17.1M
52W Change
122.5%
Annual Financials
Cash vs Debt
On the balance sheet, AVNS has $65.6M in cash with $138.4M in obligations. The ability to service this debt comfortably depends on continued operational cash generation. Free cash flow comes in at $17.1M, providing flexibility for reinvestment, buybacks, or dividends. Consistent free cash flow generation is often considered a sign of operational health. ROE of -9.2% points to negative capital efficiency, indicating how much profit the company produces per dollar of shareholder equity. ROA of 0.9% is on the lower side, which is common in asset-heavy industries. Revenue has been uneven over recent years, ranging from $587.0M to $701.2M.
A beta of 1.57 means AVNS is more volatile than average. Investors should be prepared for wider price swings relative to broader indices. No single metric tells the full story. Reviewing AVNS's risk profile alongside its fundamentals and technical indicators provides a more complete picture.